Fig. 5
From: Crotonoside exerts anti-colorectal cancer effects by suppressing KIF20A to regulate the cell cycle
CTS targets and inhibits KIF20A to suppresses CRC progression by inducing G2/M phase arrest. (A) Molecular docking of CTS with KIF20A; (B, C) CETSA assay evaluates the binding of CTS to KIF20A (n = 3); (D) Verification of KIF20A overexpression efficiency (n = 3); (E–H) Overexpressing KIF20A reverses the anti-CRC effects of CTS (n = 3).
